Literature DB >> 22238117

Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility.

Joseph S Koopmeiners1, Ziding Feng, Margaret Sullivan Pepe.   

Abstract

Many biomarkers identified in marker discovery are shown to have inadequate performance in validation studies. This motivates the use of group sequential designs that allow early termination for futility. However, an option for early termination will lead to biased estimates for studies that reach full enrollment. We propose conditional estimators and confidence intervals that correct for this bias assuming that an unadjusted estimator exists that has an independent increments covariance structure. The proposed estimators and confidence intervals are applied to conditional estimation of the receiver operating characteristic curve and the positive predictive value curve after a two-stage study that allows early termination for futility, and their performance is evaluated by simulation.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22238117      PMCID: PMC3641588          DOI: 10.1002/sim.4430

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes.

Authors:  Chaya S Moskowitz; Margaret S Pepe
Journal:  Biostatistics       Date:  2004-01       Impact factor: 5.899

2.  Group sequential design for comparative diagnostic accuracy studies: implications and guidelines for practitioners.

Authors:  Madhu Mazumdar
Journal:  Med Decis Making       Date:  2004 Sep-Oct       Impact factor: 2.583

3.  Methodological issues with adaptation of clinical trial design.

Authors:  H M James Hung; Sue-Jane Wang; Robert T O'Neill
Journal:  Pharm Stat       Date:  2006 Apr-Jun       Impact factor: 1.894

4.  Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility.

Authors:  Margaret Sullivan Pepe; Ziding Feng; Gary Longton; Joseph Koopmeiners
Journal:  Stat Med       Date:  2009-02-28       Impact factor: 2.373

5.  Nonparametric and semiparametric group sequential methods for comparing accuracy of diagnostic tests.

Authors:  Liansheng Tang; Scott S Emerson; Xiao-Hua Zhou
Journal:  Biometrics       Date:  2008-03-27       Impact factor: 2.571

6.  Exact confidence intervals following a group sequential test.

Authors:  A A Tsiatis; G L Rosner; C R Mehta
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

7.  Group sequential design for comparative diagnostic accuracy studies.

Authors:  Madhu Mazumdar; Aiyi Liu
Journal:  Stat Med       Date:  2003-03-15       Impact factor: 2.373

8.  Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome.

Authors:  Yingye Zheng; Tianxi Cai; Margaret S Pepe; Wayne C Levy
Journal:  J Am Stat Assoc       Date:  2008       Impact factor: 5.033

9.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Authors:  Jorge A Marrero; Ziding Feng; Yinghui Wang; Mindie H Nguyen; Alex S Befeler; Lewis R Roberts; K Rajender Reddy; Denise Harnois; Josep M Llovet; Daniel Normolle; Jackie Dalhgren; David Chia; Anna S Lok; Paul D Wagner; Sudhir Srivastava; Myron Schwartz
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

  9 in total
  11 in total

1.  Early termination of a two-stage study to develop and validate a panel of biomarkers.

Authors:  Joseph S Koopmeiners; Rachel Isaksson Vogel
Journal:  Stat Med       Date:  2012-10-02       Impact factor: 2.373

2.  Two-stage biomarker panel study and estimation allowing early termination for futility.

Authors:  Shanshan Zhao; Yingye Zheng; Ross L Prentice; Ziding Feng
Journal:  Biostatistics       Date:  2015-05-11       Impact factor: 5.899

3.  Response adaptive randomization procedures in seamless phase II/III clinical trials.

Authors:  Hongjian Zhu; Jin Piao; J Jack Lee; Feifang Hu; Lixin Zhang
Journal:  J Biopharm Stat       Date:  2019-08-27       Impact factor: 1.051

4.  Accounting for selection and correlation in the analysis of two-stage genome-wide association studies.

Authors:  David S Robertson; A Toby Prevost; Jack Bowden
Journal:  Biostatistics       Date:  2016-03-18       Impact factor: 5.899

5.  Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design.

Authors:  Nabihah Tayob; Kim-Anh Do; Ziding Feng
Journal:  Biometrics       Date:  2016-02-04       Impact factor: 2.571

6.  Correcting for bias in the selection and validation of informative diagnostic tests.

Authors:  David S Robertson; A Toby Prevost; Jack Bowden
Journal:  Stat Med       Date:  2015-02-01       Impact factor: 2.373

7.  Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.

Authors:  Peter K Kimani; Susan Todd; Nigel Stallard
Journal:  Stat Med       Date:  2013-02-15       Impact factor: 2.373

8.  Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials.

Authors:  Jack Bowden; Ekkehard Glimm
Journal:  Biom J       Date:  2013-12-18       Impact factor: 2.207

9.  More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.

Authors:  James Michael Menke; Md Shahidul Ahsan; Suan Phaik Khoo
Journal:  Biomark Cancer       Date:  2017-10-17

10.  Adding Rigor to Biomarker Evaluations-EDRN Experience.

Authors:  Ziding Feng; Margaret S Pepe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-11-10       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.